These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16608431)

  • 1. The Plasma Proteome: High Abundance versus Low Abundance. January 10-11, 2006, San Diego, CA, USA.
    Zhang H
    Expert Rev Proteomics; 2006 Apr; 3(2):175-8. PubMed ID: 16608431
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.
    Jaros JA; Guest PC; Bahn S; Martins-de-Souza D
    Methods Mol Biol; 2013; 1002():1-11. PubMed ID: 23625390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and plasma proteomics.
    Issaq HJ; Xiao Z; Veenstra TD
    Chem Rev; 2007 Aug; 107(8):3601-20. PubMed ID: 17636887
    [No Abstract]   [Full Text] [Related]  

  • 4. Mining the plasma proteome for disease applications across seven logs of protein abundance.
    Zhang Q; Faca V; Hanash S
    J Proteome Res; 2011 Jan; 10(1):46-50. PubMed ID: 21062094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of blood plasma/serum samples stored in biobanks: insights for clinical application.
    Tissot JD; Currat C; Sprumont D
    Expert Rev Proteomics; 2017 Aug; 14(8):643-644. PubMed ID: 28448729
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum proteomics profiling--a young technology begins to mature.
    Coombes KR; Morris JS; Hu J; Edmonson SR; Baggerly KA
    Nat Biotechnol; 2005 Mar; 23(3):291-2. PubMed ID: 15765078
    [No Abstract]   [Full Text] [Related]  

  • 7. [Undulating changes in human plasma proteome across lifespan].
    Guerrera IC
    Med Sci (Paris); 2020 Oct; 36(10):841-844. PubMed ID: 33026322
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dynamic range characterization of the trauma patient plasma proteome.
    Liu T; Qian WJ; Gritsenko MA; Xiao W; Moldawer LL; Kaushal A; Monroe ME; Varnum SM; Moore RJ; Purvine SO; Maier RV; Davis RW; Tompkins RG; Camp DG; Smith RD;
    Mol Cell Proteomics; 2006 Oct; 5(10):1899-913. PubMed ID: 16684767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the bovine uterine and plasma proteome using iTRAQ proteomics.
    Faulkner S; Elia G; Mullen MP; O'Boyle P; Dunn MJ; Morris D
    Proteomics; 2012 Jun; 12(12):2014-23. PubMed ID: 22623423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying proteomics technology to platelet research.
    García A; Watson SP; Dwek RA; Zitzmann N
    Mass Spectrom Rev; 2005; 24(6):918-30. PubMed ID: 15599945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative 2D DIGE analysis of the depleted serum proteome for biomarker discovery.
    Penno M; Ernst M; Hoffmann P
    Methods Mol Biol; 2012; 854():207-20. PubMed ID: 22311763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
    Zolotarjova N; Mrozinski P; Chen H; Martosella J
    J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-analytical operating procedures for serum Low Molecular Weight protein profiling.
    Di Girolamo F; Alessandroni J; Somma P; Guadagni F
    J Proteomics; 2010 Jan; 73(3):667-77. PubMed ID: 19766745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.
    Fang Q; Kani K; Faca VM; Zhang W; Zhang Q; Jain A; Hanash S; Agus DB; McIntosh MW; Mallick P
    PLoS One; 2011; 6(7):e23090. PubMed ID: 21829587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays.
    Schwenk JM; Omenn GS; Sun Z; Campbell DS; Baker MS; Overall CM; Aebersold R; Moritz RL; Deutsch EW
    J Proteome Res; 2017 Dec; 16(12):4299-4310. PubMed ID: 28938075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical proteomics: written in blood.
    Liotta LA; Ferrari M; Petricoin E
    Nature; 2003 Oct; 425(6961):905. PubMed ID: 14586448
    [No Abstract]   [Full Text] [Related]  

  • 18. The dynamic range problem in the analysis of the plasma proteome.
    Hortin GL; Sviridov D
    J Proteomics; 2010 Jan; 73(3):629-36. PubMed ID: 19619681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response: platelet transcriptome and proteome--relation rather than correlation.
    Geiger J; Burkhart JM; Gambaryan S; Walter U; Sickmann A; Zahedi RP
    Blood; 2013 Jun; 121(26):5257-8. PubMed ID: 23813942
    [No Abstract]   [Full Text] [Related]  

  • 20. Sampling the N-terminal proteome of human blood.
    Wildes D; Wells JA
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4561-6. PubMed ID: 20173099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.